Molecular Partners AG (SWX: MOLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
4.800
-0.100 (-2.04%)
Nov 20, 2024, 5:30 PM CET

Molecular Partners AG Revenue

Molecular Partners AG had revenue of 681.00K CHF in the quarter ending September 30, 2024, a decrease of -73.20%. This brings the company's revenue in the last twelve months to 6.00M, down -31.03% year-over-year. In the year 2023, Molecular Partners AG had annual revenue of 7.04M, down -96.29%.

Revenue (ttm)
6.00M
Revenue Growth
-31.03%
P/S Ratio
26.41
Revenue / Employee
35.73K
Employees
168
Market Cap
176.94M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.04M-182.56M-96.29%
Dec 31, 2022189.60M179.85M1,843.82%
Dec 31, 20219.75M410.00K4.39%
Dec 31, 20209.34M-11.04M-54.16%
Dec 31, 201920.38M10.03M96.84%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 60.58B
Roche Holding AG 60.58B
Novartis AG 42.18B
Lonza Group AG 6.70B
Galderma Group AG 3.88B
Sonova Holding AG 3.63B
Straumann Holding AG 2.54B
Ypsomed Holding AG 617.07M
Revenue Rankings